| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Department of Anesthesiology, Queen's University, Kingston, Ontario, Canada.
Dr. Brian Milne, Department of Anesthesiology, Kingston General Hospital, 76 Stuart Street, Kingston, Ontario K7L 2V7, Canada. Phone: 613-548-7827; Fax: 613-548-1375; E-mail: milneb{at}post.queensu.ca
| Abstract |
|---|
|
|
|---|
Clinical features: A 73-yr-old woman with long-standing COPD and cor pulmonale admitted with pericardial effusion and tamponade had surgery for a pericardial window receiving a total of ketamine 450 mg iv. Arterial pCO2 increased from 71.8 mmHg preoperatively to 96 mmHg intraoperatively postdrainage of 1000 mL of effusion. Hemodynamic stability and SpO2 >93% were maintained. Intubation was avoided and concerns of increased pulmonary vascular resistance and potential for right ventricular failure in an already compromised right ventricle were not observed clinically.
Conclusion: In this patient with pericardial tamponade, COPD and CO2 retention, the advantages of ketamine included maintaining spontaneous ventilation, avoiding institution and weaning of mechanical ventilation, bronchodilation and relative preservation of the CO2 response curve. Deleterious effects on right ventricular afterload were not observed.
| Introduction |
|---|
|
|
|---|
| Case report |
|---|
|
|
|---|
The following day she was in distress with increasing shortness of breath. She was unable to lie down stating she had never been this bad before. There had been no improvement with salbutamol inhalation and she had been started on prednisone. Her blood pressure was 116/68 mmHg, heart rate 110 beatsmin1, pulsus paradoxus 26 mmHg and SpO2 93% on nasal O2 4 Lmin1. Examination revealed decreased air entry with faint wheezes, JVP 8 cm H2O, with poorly palpable peripheral pulses. The patient refused to have another pericardiocentesis "awake" because of her previous experience and requested surgical drainage be performed under a general anesthetic.
Initially a thoracoscopic pericardial window was considered but in consultation with the attending anesthesiologist it was decided that problems with collapsing the emphysematous lung, difficulty in tolerating one lung anesthesia, and lack of an expeditious resolution made a subxiphoid approach to the pericardial window preferable. Anemia was corrected with two units of packed cells bringing the hemoglobin concentration to 106 mgdL1. Electrolytes and liver function tests were normal, an arterial blood gas on 4 Lmin1 nasal O2 showed pH 7.38, PO2 78.9 mmHg, PCO2 71.8 mmHg, HCO3 37.5 mmoLL1. Her electrocardiogram showed a sinus tachycardia with low voltage and her chest x-ray suggested a large pericardial effusion.
The patient eventually consented to needle drainage of the pericardial effusion prior to definitive surgery providing she was not aware. An echocardiogram demonstrated a very large anterior and posterior pericardial effusion and a chronically dilated right ventricle with systolic and diastolic collapse. Under echo guidance, in the intensive care unit (ICU) in the sitting position, 400 mL of chocolate coloured pericardial fluid was drained. Three boluses of midazolam 0.5 mg and propofol 20 mg iv were given during the procedure. Hemodynamics remained stable throughout the procedure and at the termination, right ventricular collapse was still present on echocardiogram. In the operating room with continuous intra-arterial monitoring, automated segment lead I, II, and V analysis, nasal O2 4 Lmin1, the patient was prepped and draped in the sitting position. After administration of glycopyrrolate 0.3 mg, and midazolam 1 mg, anesthesia was induced with ketamine in 25 mg increments to a total of 100 mg. Blood pressure was 120 mmHg systolic, and heart rate 100 beatsmin1. The patient was gradually returned to the supine position and lidocaine 1% was infiltrated locally. Subxiphoid drainage of 1000 mL of effusion increased her blood pressure to 140 mmHg systolic. Heart rate was 100115 beatsmin1 and SpO2 >93% throughout. An intraoperative blood gas postdrainage showed a pH 7.28, PO2 102 mmHg, pCO2 96 mmHg, HCO3 44 mmoLL1. A total of 450 mg of ketamine were used during the procedure. The xiphisternum and a large ellipse of anterior pericardium were excised along with talc poudrage of the pericardial space. She returned to the ICU with stable hemodyamics and had no recall of events. There were no postoperative problems except for a pneumothorax, which required insertion of a left-sided chest tube, probably due to the pericardiocentesis. She was discharged home five days postoperatively and analysis of the pericardial fluid was negative for malignancy, showing only inflammatory cells.
| Discussion |
|---|
|
|
|---|
Although ketamine can have myocardial depressant effects in vitro and in patients who are maximally stressed with depleted catecholamines,6 in this case ketamine produced no decrease in blood pressure. The patient refused to be monitored with a pulmonary artery catheter due to her previous experience of an introducer having been placed into the carotid artery. This prevented monitoring of cardiac output and pulmonary artery pressures. The effect of ketamine on the pulmonary vasculature was a main consideration due to COPD with associated loss of pulmonary capillaries and arterial hypoxia leading to pulmonary vasoconstriction. Spotoft et al. found increases in pulmonary artery pressures mainly through increases in pulmonary vascular resistance unrelated to changes in PaO2 and PaCO2 with ketamine.4 There was initial concern that this increase in pulmonary vascular resistance may be greater than the increase in systemic vascular resistance which could cause an increase in shunt fraction. However, Rees et al. found no increase in shunt fraction using ketamine in humans during one lung anesthesia when compared to enflurane.7 One of the main problems with studies on the effects of ketamine on the pulmonary vasculature is controlling for the effects of respiratory depression on partial airway obstruction. Balfors et al. found no change in pulmonary vascular resistance during ketamine anesthesia in adults with assisted ventilation.8 Despite the effects of ketamine on pulmonary vasculature, its beneficial bronchodilating effect which parallels that of inhalational agents has been used in the treatment of reactive airways.9 In our patient with COPD, ketamine's bronchodilating effects may also have been advantageous.
Increases in PaCO2 were seen intraoperatively and this may have been due to the change of position from sitting to supine, diaphragmatic dysfunction from an upper abdominal incision, as well as the respiratory depressant effects of midazolam and ketamine. Surgical anesthesia and spontaneous ventilation can be achieved in numerous ways, but the majority are associated with direct myocardial depressant effects and decreases in systemic vascular resistance. Inhalational agents shift the CO2 response curve to the right and the associated hypercarbia may be detrimental to the patient with COPD and CO2 retention. Acute or chronic respiratory acidosis may cause central nervous side effects, increase right ventricular afterload, and cause dysrhythmias, all complications which should be avoided in patients with limited myocardial reserve. Although ketamine is a respiratory depressant, its' effects are mild10,11 and even though there is no guarantee against pulmonary aspiration, respiration is maintained with relatively intact laryngeal reflexes. In humans, ketamine alone causes mild respiratory depression similar but at a lesser degree to that seen with narcotics in the premedicant or analgesic dose range in that the slope of the ventilatory response to CO2 is unchanged, while the response curve is shifted to the right.12 Maintaining spontaneous ventilation may be better tolerated in the patient with cardiac tamponade.13 Increased tracheobronchial secretions may be attenuated with an antisialogogue and apneic spells may be minimized by titrating doses with slow injections.
Thus, in this patient with pericardial tamponade, COPD and CO2 retention, the advantages of ketamine included maintaining spontaneous ventilation, avoiding institution and weaning of mechanical ventilation, bronchodilation and relative preservation of the CO2 response curve, lack of cardiac depression, intense somatic analgesia, and amnesia. These advantages were felt to outweigh the disadvantages of effects on pulmonary vasculature, increased tracheobronchial secretions, and emergence reactions. The theoretical concerns of increased pulmonary vascular resistance and potential for right ventricular failure in an already compromised right ventricle were not observed clinically, and we were able to avoid intubation and mechanical ventilation in our patient with COPD and CO2 retention.
Revision received December 12, 2001. Accepted for publication October 31, 2001.
| References |
|---|
|
|
|---|
2
Stanley TH, Weidauer HE. Anesthesia for the patient with cardiac tamponade. Anesth Analg 1973; 52: 1103.
3 Kaplan JA, Bland JW Jr, Dunbar RW. The perioperative management of pericardial tamponade. South Med J 1976; 69: 4179.[Medline]
4 Spotoft H, Korshin JD, Sørensen MB, Skovsted P. The cardiovascular effects of ketamine used for induction of anaesthesia in patients with valvular heart disease. Can Anaesth Soc J 1979; 26: 4637.[Medline]
5 Breen PH, MacVay MA. Pericardial tamponade: a case for awake endotracheal intubation (Letter). Anesth Analg 1996; 83: 658.
6 Stoelting R. Nonbarbiturate induction drugs. In: Stoelting R (Ed.). Pharmacology & Physiology in Anesthetic Practice, 3rd ed., Philadelphia, Pennsylvania: Lippincott-Raven, 1999: 14057.
7
Rees DI, Gaines III GY. One-lung anesthesiaa comparison of pulmonary gas exchange during anesthesia with ketamine or enflurane. Anesth Analg 1984; 63: 5215.
8
Bålfors E, Häggmark S, Nyhman H, Rydvall A, Reiz S. Droperidol inhibits the effects of intravenous ketamine on central hemodynamics and myocardial oxygen consumption in patients with generalized atherosclerotic disease. Anesth Analg 1983; 62: 1937.
9 Sarma VJ. Use of ketamine in acute severe asthma. Acta Anaesthesiol Scand 1992; 36: 1067.[Medline]
10 Soliman MG, Brindle GF, Kuster G. Response to hypercapnia under ketamine anaesthesia. Can Anaesth Soc J 1975; 22: 48694.[Medline]
11
Reich DL, Silvay G. Ketamine: an update on the first twenty-five years of clinical experience. Can J Anaesth 1989; 36: 18697.
12 Bourke DL, Malit LA, Smith TC. Respiratory interactions of ketamine and morphine. Anesthesiology 1987; 66: 1536.[Medline]
13
Möller CT, Schoonbee CG, Rosendorff C. Haemodynamics of cardiac tamponade during various modes of ventilation. Br J Anaesth 1979; 51: 40914.
This article has been cited by other articles:
![]() |
G. D. Williams, B. M. Philip, L. F. Chu, M. G. Boltz, K. Kamra, H. Terwey, G. B. Hammer, S. B. Perry, J. A. Feinstein, and C. Ramamoorthy Ketamine Does Not Increase Pulmonary Vascular Resistance in Children with Pulmonary Hypertension Undergoing Sevoflurane Anesthesia and Spontaneous Ventilation Anesth. Analg., December 1, 2007; 105(6): 1578 - 1584. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |